The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable.
Michael R. Samardzija, PhD
Advertisement
Michael R. Samardzija, PhD, is counsel at Bracewell & Guiliani LLP
Articles by Michael R. Samardzija, PhD
Advertisement
Latest Updated Articles
Recent Patent Rulings Can Impede the Progress of Personalized MedicinePublished: August 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
